Results 121 to 130 of about 12,555 (213)

Beyond antifungals: vaginal ceramides as a barrier-restorative strategy for recurrent vulvovaginal candidiasis in Ehlers-Danlos syndrome. [PDF]

Ann Med Surg (Lond)
Amjad M, Fazal M, Talha M, Ali U, Mahato RK.   +4 more
europepmc   +1 more source

Characterization of the vaginal microbiome and its metabolic potential in Colombian patients with recurrent vulvovaginal candidiasis. [PDF]

Med Mycol
Consuegra-Asprilla JM, Cuesta-Astroz Y, González Á.   +2 more
europepmc   +1 more source

Core outcome sets for clinical trials and observational studies in vulvovaginal disease [PDF]

, 2017
Foster, David C., Kirtschig, Gudula, Simpson, Rosalind C., Stockdale, Colleen K.   +3 more
core   +2 more sources

Vulvovaginal candidiasis and antifungal susceptibility pattern of isolated Candida spp. among women in Aden Governorate, Yemen. [PDF]

BMC Infect Dis
Gubran ANM, Al-Baghdadi MAA, Al-Haidary NM.   +2 more
europepmc   +1 more source

The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]

Infect Drug Resist
Zubovskaia A, Vazquez JA.
europepmc   +1 more source

Serum interleukin-6 levels in murine models of Candida albicans infection [PDF]

, 2017
Czudar, Anita, Horváth, László, Kovács, Renátó László, Kónya, József, Majoros, László, Szakács, Levente   +5 more
core   +1 more source

Reply to Takada and Komine-Aizawa, "Bacterial vaginosis and the gut-vagina axis". [PDF]

Microbiol Spectr
Li M, Zhang Q, Wu T, Hu D, Wang S, Zhang J.   +5 more
europepmc   +1 more source

Nationwide epidemiology of candidiasis in Panama, 2010-2020. [PDF]

Sci Rep
Arana IC, Añino Y, Murillo D, Ramírez-Camejo LA.   +3 more
europepmc   +1 more source

Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis [PDF]

core   +1 more source